Sun Life to buy majority shares in Montreal-based Dialogue

On July 26, 2023, Dialogue Health Technologies Inc., Canada's premier virtual care platform, entered a definitive agreement with Sun Life Financial Inc. Under this deal, Sun Life will acquire all of Dialogue's common shares for $5.15 each, valuing the company at roughly $365 million. This price marks a 43.1% premium over Dialogue's closing share value on the Toronto Stock Exchange on July 25. After a strategic review by Dialogue, overseen by an independent committee, the company's Board unanimously endorsed the arrangement. This union underscores the shared goal of both firms to champion Canadians' health and wellness. It paves the way for Dialogue to maintain its growth momentum, leveraging the combined resources of both entities. Cherif Habib, Dialogue's CEO, voiced his positive outlook on the partnership, underscoring their strong rapport with Sun Life. Jacques Goulet, Sun Life Canada's President, reiterated this commitment to enhancing Canadian healthcare. The deal is set to finalize in Q4 2023, pending shareholder, court, and regulatory approvals. Influential shareholders, holding approximately 30.5% of the voting shares, have pledged their support. National Bank Financial and Scotiabank are advising Dialogue, while legal counsels include Osler, Hoskin & Harcourt LLP for Dialogue, and Stikeman Elliott LLP for the Rolling Shareholders.

Merger & Acquisition
Healthcare
$ 365,000,000
Closed
03 October 2023